跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
immunocytokines
首页
药物
immunocytokines
immunocytokines
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTI-PD-L1 ANTIBODIES
EP 3471754 A1
申请人: KYMAB LTD
优先权: 2016
CN
EP
US
WO
9 件公开
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
EP 2537933 A1
申请人: INST NAT SANTE RECH MED
优先权: 2011
CN
EP
US
7 件公开
TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo
US 11440960 B2
申请人: KYMAB LTD
优先权: 2017
US
WO
5 件公开
Antibodies and immunocytokines
US 9567399 B1
申请人: KYMAB LTD
优先权: 2016
US
4 件公开
CHIMERIC IMMUNOCYTOKINES
EP 4676517 A2
申请人: DANA FARBER CANCER INST INC
优先权: 2023
EP
US
WO
3 件公开
TNF SUPERFAMILY MEMBER IMMUNOCYTOKINE AND USES THEREOF
EP 4683949 A1
申请人: GILEAD SCIENCES INC
优先权: 2023
CN
EP
WO
3 件公开
LIGHT CHAIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE THEREOF
EP 3626739 A1
申请人: GILLIES STEPHEN D
优先权: 2011
EP
US
3 件公开
Immunocytokines for treatment of autoimmune and inflammatory conditions
US 12649782 B2
申请人: HORIZON THERAPEUTICS IRELAND DAC
优先权: 2020
US
WO
3 件公开
TRISPECIFIC COMPOSITIONS COMPRISING IL-2, VEGF BINDING DOMAINS, AND PD-1 BINDING DOMAINS
US 20260139053 A1
申请人: BRIGHT PEAK THERAPEUTICS AG
优先权: 2024
US
WO
3 件公开
Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
US 7517526 B2
申请人: MERCK PATENT GMBH
优先权: 2001
US
3 件公开
第 1 / 5 页
上一页
下一页
药物
反馈